Skip to content

Patient's Knowledge on Their Anticoagulating and Anti Platelet Treatment St Joseph's Hospital)

Current Situation of the Patient's Knowledge on Their Anticoagulating and Anti Platelet Treatment in GHPSJ (St Joseph's Hospital)

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03304977
Enrollment
100
Registered
2017-10-09
Start date
2016-06-06
Completion date
2016-10-30
Last updated
2017-10-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coagulation Disorder

Brief summary

Oral antigoagulant are used more than 60 years in thrombotic diseases. Even they are indispensable, the haemorragic risk is high.That's why it's the main reason of hospitalization for iatrogeny.The complication's reasons are mainly linked to errors of drug intake, drugs interaction and the lack of understanding the treatment.Moreover, the antiplatelet agglutening treatment is frequently added to anticoagulant treatment.This increases the haemorragic risk.Different means were used to minimize the risk , like INR follow up. The purpose of the study is to evaluate smartphone use to follow the patients'treatment.

Detailed description

Two questionnaire via smartphone with 15 days gap.

Interventions

OTHERquestionnaire via smartphone

questionnaire via smartphone

Sponsors

Fondation Hôpital Saint-Joseph
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* patient under ant-thrombotic treatment * hospitalized in vascular medecine service

Exclusion criteria

* refusing the participation

Design outcomes

Primary

MeasureTime frameDescription
smartphone use level15 daysevaluation of the interest of patient to use their smartphone in the purpose to follow their anticoagulant treatment

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026